Omeros | OMER - Trade Debtors


Omeros reported $8.08M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Adma Biologics USD 135.86M 22.57M Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Cytokinetics USD 6.83M 10.94M Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Immunic USD 333K 156K Dec/2025
Insmed USD 178.55M 37.7M Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
MacroGenics USD 10.42M 2.95M Mar/2026
Omeros USD 8.08M 440K Jun/2024
Pacira USD 125.64M 1.57M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Rockwell Medical USD 10.84M 250K Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
United Therapeutics USD 312M 38.2M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026